Literature DB >> 17635612

Interleukin-21 differentially affects human natural killer cell subsets.

Katy Wendt1, Esther Wilk, Sabine Buyny, Reinhold Ernst Schmidt, Roland Jacobs.   

Abstract

Interleukin-21 (IL-21) is a cytokine with pleiotropic effects on various cell types including dendritic cells, B cells, T cells and natural killer (NK) cells. To evaluate if IL-21 affects human NK cell subpopulations in a similar fashion, functional studies were performed on CD56(dim) and CD56(bright) NK cells, both bearing IL-21 receptors at identical densities. Stimulation with IL-21 strongly induced proliferation of CD56(bright) NK cells and cytotoxicity against K562 target cells was preferentially augmented in CD56(dim) NK cells. In contrast, stimulation with IL-2 and IL-21 alone or in combination failed to induce interferon-gamma and tumour necrosis factor-alpha production in the two NK cell subsets. Intracellular analysis of signal transducer and activator of transcription (STAT) proteins revealed that IL-21 by itself induces phosphorylation of STAT1 and STAT3 in CD56(dim) NK cells, and to an even higher degree in CD56(bright) NK cells. In this CD56(bright) NK cell population alone, IL-2 weakly phosphorylated STAT1 and STAT3, which was further increased when cells were treated with the combination of both cytokines. In contrast, STAT5 was strongly phosphorylated only in CD56(bright) NK cells by low-dose IL-2, while IL-21 did not affect STAT5 at all. In summary, we present data indicating that the NK-cell-directed cytokines IL-2 and IL-21 not only affect functions in NK cell subpopulations differently but can also act additively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17635612      PMCID: PMC2266033          DOI: 10.1111/j.1365-2567.2007.02675.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

1.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

Authors:  T A Fehniger; M H Shah; M J Turner; J B VanDeusen; S P Whitman; M A Cooper; K Suzuki; M Wechser; F Goodsaid; M A Caligiuri
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells.

Authors:  Mari Strengell; Sampsa Matikainen; Jukka Sirén; Anne Lehtonen; Don Foster; Ilkka Julkunen; Timo Sareneva
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

3.  IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors.

Authors:  Simona Sivori; Claudia Cantoni; Silvia Parolini; Emanuela Marcenaro; Romana Conte; Lorenzo Moretta; Alessandro Moretta
Journal:  Eur J Immunol       Date:  2003-12       Impact factor: 5.532

4.  IL-21 enhances tumor rejection through a NKG2D-dependent mechanism.

Authors:  Rayna Takaki; Yoshihiro Hayakawa; Andrew Nelson; Pallavur V Sivakumar; Steven Hughes; Mark J Smyth; Lewis L Lanier
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

5.  Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex.

Authors:  H Asao; C Okuyama; S Kumaki; N Ishii; S Tsuchiya; D Foster; K Sugamura
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

6.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Authors:  Tal I Arnon; Hagit Achdout; Ofer Levi; Gal Markel; Nivin Saleh; Gil Katz; Roi Gazit; Tsufit Gonen-Gross; Jacob Hanna; Efrat Nahari; Angel Porgador; Alik Honigman; Bodo Plachter; Dror Mevorach; Dana G Wolf; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2005-04-10       Impact factor: 25.606

7.  Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12.

Authors:  P T Mehrotra; R P Donnelly; S Wong; H Kanegane; A Geremew; H S Mostowski; K Furuke; J P Siegel; E T Bloom
Journal:  J Immunol       Date:  1998-03-15       Impact factor: 5.422

8.  Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.

Authors:  K Handa; R Suzuki; H Matsui; Y Shimizu; K Kumagai
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

9.  In vivo antitumor activity of interleukin 21 mediated by natural killer cells.

Authors:  Gang Wang; Mary Tschoi; Rosanne Spolski; Yanyan Lou; Katsutoshi Ozaki; Chiguang Feng; Grace Kim; Warren J Leonard; Patrick Hwu
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

10.  Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.

Authors:  Mark J Smyth; Morgan E Wallace; Stephen L Nutt; Hideo Yagita; Dale I Godfrey; Yoshihiro Hayakawa
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

View more
  20 in total

Review 1.  CD56bright natural killer (NK) cells: an important NK cell subset.

Authors:  Aurélie Poli; Tatiana Michel; Maud Thérésine; Emmanuel Andrès; François Hentges; Jacques Zimmer
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

Review 2.  Strategies to enhance NK cell function for the treatment of tumors and infections.

Authors:  Jacquelyn Freund-Brown; Leilani Chirino; Taku Kambayashi
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

3.  Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma.

Authors:  Markus Granzin; Ana Stojanovic; Matthias Miller; Richard Childs; Volker Huppert; Adelheid Cerwenka
Journal:  Oncoimmunology       Date:  2016-08-05       Impact factor: 8.110

Review 4.  Challenges of NK cell-based immunotherapy in the new era.

Authors:  Fang Fang; Weihua Xiao; Zhigang Tian
Journal:  Front Med       Date:  2018-07-25       Impact factor: 4.592

Review 5.  Interleukin-21: a multifunctional regulator of immunity to infections.

Authors:  John S Yi; Maureen A Cox; Allan J Zajac
Journal:  Microbes Infect       Date:  2010-09-09       Impact factor: 2.700

6.  Interleukin 21 up-regulates perforin-mediated cytotoxic activity of human intra-epithelial lymphocytes.

Authors:  Ellen C Ebert
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

7.  Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.

Authors:  Shiguo Zhu; Prasad V Phatarpekar; Cecele J Denman; Vladimir V Senyukov; Srinivas S Somanchi; Hoainam T Nguyen-Jackson; Emily M Mace; Alexandra F Freeman; Stephanie S Watowich; Jordan S Orange; Steven M Holland; Dean A Lee
Journal:  Blood       Date:  2014-06-02       Impact factor: 22.113

8.  Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells.

Authors:  Cecele J Denman; Vladimir V Senyukov; Srinivas S Somanchi; Prasad V Phatarpekar; Lisa M Kopp; Jennifer L Johnson; Harjeet Singh; Lenka Hurton; Sourindra N Maiti; M Helen Huls; Richard E Champlin; Laurence J N Cooper; Dean A Lee
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

9.  Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12.

Authors:  Amanda R Campbell; Kelly Regan; Neela Bhave; Arka Pattanayak; Robin Parihar; Andrew R Stiff; Prashant Trikha; Steven D Scoville; Sandya Liyanarachchi; Sri Vidya Kondadasula; Omkar Lele; Ramana Davuluri; Philip R O Payne; William E Carson
Journal:  BMC Med Genomics       Date:  2015-10-15       Impact factor: 3.063

Review 10.  Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation.

Authors:  Markus Granzin; Juliane Wagner; Ulrike Köhl; Adelheid Cerwenka; Volker Huppert; Evelyn Ullrich
Journal:  Front Immunol       Date:  2017-04-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.